VCT220
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for VCT220, covering 2025-07-01 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: A Drug Drug Interaction Study to Evaluate the Effect of VCT220 on the Pharmacokinetics of Repaglinide, Rosuvastatin, and Digoxin in Healthy, Overweight, and Obese Subjects [Phase 1]